In the use case in drug repurposing for Alzheimer’s Disease, EcoXAI evaluated 103 drug candidates and identified 79 novel candidates whose predictive models exceeded a randomized baseline, including the CCR5 antagonist Maraviroc, whose generated hypothesis was subsequently supported by the literature.
Abstract
Motivation As biomedical datasets and knowledge graphs continue to grow in size, complexity, and heterogeneity, navigating and extracting actionable insights from them presents a major bottleneck for researchers. There is a clear need for autonomous analytical solutions that can utilize recent advancements in agentic AI such as agent harnessing and loop engineering without introducing hallucination or workflow fragmentation. Researchers, regardless of technical expertise, need tools that streamline complex data analysis and deliver meaningful, actionable insights grounded in both data and established biomedical knowledge. EcoXAI addresses this by introducing a modular, customizable, containerized multi-agent system that structures analysis into explicit pipeline execution stages, lowering the computational barrier for clinical and translational researchers. Result EcoXAI replaces monolithic AI text interfaces with an autonomous execution-driven framework with specialized bioinformatics agents for delivering proactive, data-driven insights grounded in established biological knowledge. Unlike purely LLM-driven or less integrated AI solutions prone to hallucinations or biologically implausible outcomes, EcoXAI’s multi-agent framework, which leverages modern agentic management and explicit knowledge graph integration, provides greater transparency and verifiability in its reasoning. In our use case in drug repurposing for Alzheimer’s Disease, EcoXAI evaluated 103 drug candidates and identified 79 novel candidates whose predictive models exceeded a randomized baseline, including the CCR5 antagonist Maraviroc, whose generated hypothesis was subsequently supported by the literature. These results demonstrate the potential of knowledge graph-grounded AI agents to accelerate hypothesis-driven biomedical research. Availability and implementation EcoXAI is available on GitHub at: https://github.com/EpistasisLab/EcoXAI. Contact jason.moore@csmc.edu
Findings show that PromptBio can coordinate complex biomedical analyses under researcher oversight, offering an accessible approach for accelerating scientific iteration and transforming research questions into transparent, reusable computational workflows.
Min-Zhe Zhang, Wen-Hao Gu, Bo-Wei Han et al.· bioRxiv· 0 citations
LungChat is deployed as a hierarchical multi-agent architecture in which a supervisor decomposes natural-language questions into parallel, tool-grounded tasks spanning single-cell and spatial analyses, literature and clinical-trial synthesis, and drug repurposing.
Pankaj Rajdeo, S. Asanuma, Michal Kouril et al.· bioRxiv· 0 citations
A scoping review with systematic evidence mapping across five electronic sources, screened 1,649 exportable records, and provisionally included 557 unique studies that met predefined criteria for goal-directed task execution, tool use, interaction with external resources, feedback-based refinement, or multi-agent colla...
Zheng Tong, Yang Liu, Wan-Shu Fan et al.· arXiv.org· 0 citations
A detailed review of the current state of agentic AI is provided, starting with the evolution of AI and the concept of a medical agent, providing a structured foundation for understanding the design, deployment, governance, and limitations of agentic AI systems in modern healthcare ecosystems.
The GenXAI vision is presented, a system architecture that combines Genomic Language Models with Explainable AI (XAI) and physician-facing visual interfaces to support trustworthy, reproducible microbial species identification from metagenomic data.
Andrea Esposito, Paolo Buono, R. Lanzilotti· TRI-IVIS@AVI· 1 citation
DoctorAgents is proposed, an agentic AI framework that autonomously constructs and optimizes end-to-end ML pipelines through specialized large language model (LLM) agents for generation, validation, and refinement.
Ruilin Wang, Bo-Hong Wang, Elizabeth Kourbatski et al.· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.